Nils Ostermann
Impact in
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
Papers in
-
- Biochemical and Molecular Research 6
- Receptor Mechanisms and Signaling 3
- Co-authors
- Manfred Konrad (5 shared papers)Arnon Lavie (5 shared papers)Roger S. Goody (5 shared papers)R. Brundiers (4 shared papers)Ilme Schlichting (4 shared papers)Jochen Reinstein (4 shared papers)T. Veit (4 shared papers)Bernd Gerhartz (6 shared papers)
- Journals
- Journal of Molecular Biology (3 papers)ACS Medicinal Chemistry Letters (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Biochemistry (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Nils Ostermann
22 papers receiving 500 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 119
- Virology 28
- Molecular Biology 351
- Physiology 20
- Genetics 40
Countries citing papers authored by Nils Ostermann
This map shows the geographic impact of Nils Ostermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Ostermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Ostermann more than expected).
Fields of papers citing papers by Nils Ostermann
This network shows the impact of papers produced by Nils Ostermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Ostermann. The network helps show where Nils Ostermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Nils Ostermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 90 | |
| 2 | 1998 | 79 | |
| 3 | 1999 | 55 | |
| 4 | 2000 | 39 | |
| 5 | 2015 | 39 | |
| 6 | 2005 | 36 | |
| 7 | 2003 | 31 | |
| 8 | 2004 | 26 | |
| 9 | 2017 | 20 | |
| 10 | 2014 | 15 | |
| 11 | 2021 | 12 | |
| 12 | 2019 | 12 | |
| 13 | 2013 | 11 | |
| 14 | 2014 | 10 | |
| 15 | 2024 | 7 | |
| 16 | 2018 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2014 | 6 | |
| 19 | 1999 | 4 | |
| 20 | 2023 | 4 |
About Nils Ostermann
Nils Ostermann is a scholar working on Molecular Biology, Organic Chemistry, Materials Chemistry, Infectious Diseases and Renewable Energy, Sustainability and the Environment, having authored 24 papers that have together received 514 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (6 papers), Enzyme Structure and Function (4 papers), HIV/AIDS drug development and treatment (4 papers), Renin-Angiotensin System Studies (3 papers), Ammonia Synthesis and Nitrogen Reduction (3 papers), Receptor Mechanisms and Signaling (3 papers), CO2 Reduction Techniques and Catalysts (3 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Infectious Diseases (119 citations), Virology (28 citations), Molecular Biology (351 citations), Physiology (20 citations) and Genetics (40 citations). Nils Ostermann has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Manfred Konrad, Arnon Lavie, Roger S. Goody, R. Brundiers, Ilme Schlichting, Jochen Reinstein, T. Veit, Bernd Gerhartz, Inke Siewert and Susanne Worpenberg. Their work appears in journals such as Journal of Molecular Biology, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.